HEMK2 and neoplasm: Furthermore, we considered the relationship of N6AMT1 expression with clinical factors including age, gender and tumor stage; the results showed that N6AMT1 was differentially expressed in elderly patients aged ≥65 years in the THYM group (Figure 2C).